PatientsVille.com Logo

PatientsVille

Alprostadil Side Effects

Common Alprostadil Side Effects


The most commonly reported Alprostadil side effects (click to view or check a box to report):

Cardiac Failure (22)
Condition Aggravated (17)
Pyrexia (15)
Pulmonary Oedema (15)
Priapism (12)
Pleural Effusion (12)
Dyspnoea (10)
Myocardial Infarction (9)
Blood Pressure Decreased (9)
Bursitis (8)
Atrial Fibrillation (8)
Chills (8)
Respiratory Arrest (8)
Loss Of Consciousness (8)
Pneumonia (8)
Pain In Extremity (8)
Aspartate Aminotransferase Increased (7)
Chest Pain (7)
Pulmonary Congestion (7)
Interstitial Lung Disease (7)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Alprostadil Side Effects Reported to FDA

The following Alprostadil reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Alprostadil on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anxiety, Chest Pain, Dyspnoea, Feeling Abnormal, Palpitations
This is a report of a 71-year-old female patient (weight: NA) from POLAND, suffering from the following symptoms/conditions: peripheral ischaemia, who was treated with Alprostadil (dosage: 60 Mcg (60 Mg 1 In 1 Day(s)) Intravenous Drip, start time: Oct 23, 2007), combined with:
  • Gentamicin
  • Dolargan (pethidine Hydrochloride)
  • Polfilin (pentoxifylline)
  • Sadamin (xantinol Nicotinate)
  • Enoxaparin Sodium
  • Mixtard (insulin Injection, Isophane)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Anxiety
  • Chest Pain
  • Dyspnoea
  • Feeling Abnormal
  • Palpitations
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Alprostadil treatment in female patients, resulting in anxiety side effect. The patient was hospitalized.

Erythema, Nail Dystrophy, Psoriatic Arthropathy, Pustular Psoriasis, Skin Lesion, Swelling, Therapeutic Response Decreased
This report suggests a potential Alprostadil Erythema, Nail Dystrophy, Psoriatic Arthropathy, Pustular Psoriasis, Skin Lesion, Swelling, Therapeutic Response Decreased side effect(s) that can have serious consequences. A 81-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: arterial occlusive disease and used Alprostadil (dosage: Intravenous (not Otherwise Specified)) starting NS. Soon after starting Alprostadil the patient began experiencing various side effects, including:
  • Erythema
  • Nail Dystrophy
  • Psoriatic Arthropathy
  • Pustular Psoriasis
  • Skin Lesion
  • Swelling
  • Therapeutic Response Decreased
Drugs used concurrently: NA.The patient was hospitalized. Although Alprostadil demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as erythema, may still occur.

Pleural Effusion, Pulmonary Oedema
This Pleural Effusion, Pulmonary Oedema problem was reported by a consumer or non-health professional from JAPAN. A 75-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: diabetic gangrene. On Oct 04, 2007 this consumer started treatment with Alprostadil (dosage: 60 Mcg Intravenous Drip). The following drugs were being taken at the same time:
  • Cefazolin Sodium
  • Vancomycin
  • Magnesium Oxide Heavy (magnesium Oxide Heavy)
  • Etodolac
  • Serapeptase (serrapeptase)
  • Beraprost Sodium (beraprost Sodium)
  • Bicalutamide
  • Neo Minophagen
When commencing Alprostadil, the patient experienced the following unwanted symptoms/side effects:
  • Pleural Effusion
  • Pulmonary Oedema
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pleural effusion, may become evident only after a product is in use by the general population.

Pulmonary Oedema
This is a report of a 75-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: diabetic gangrene and was treated with Alprostadil (dosage: 60 Mcg) starting Sep 19, 2007. Concurrently used drugs:
  • Cefazolin Sodium
  • Vancomycin
Soon after that, the consumer experienced the following side effects:
  • Pulmonary Oedema
This opens a possibility that Alprostadil treatment could cause the above reactions, including pulmonary oedema, and some male subjects may be more susceptible.


Gastrointestinal Haemorrhage
A 66-year-old male patient (weight: NA) from UKRAINE with the following symptoms/conditions: peripheral ischaemia started Alprostadil treatment (dosage: 2 X 40 Ug Per Day) on Jul 19, 2004. Soon after starting Alprostadil treatment, the subject experienced various side effects, including:
  • Gastrointestinal Haemorrhage
Concurrently used drugs:
  • Glibanclamide (glibenclamide)
This finding indicates that some male patients could be more vulnerable to Alprostadil.

Arrhythmia, Atrial Fibrillation, Gait Disturbance, Gastrointestinal Haemorrhage, Haematemesis, Pneumonia, Respiratory Arrest, Shock Haemorrhagic
A 65-year-old male patient from JAPAN (weight: NA) experienced symptoms, such as: skin ulcer and was treated with Alprostadil(dosage: 80 Mcg; Intravenous Drip). The treatment was initiated on Feb 01, 2007. After that a consumer reported the following side effect(s):
  • Arrhythmia
  • Atrial Fibrillation
  • Gait Disturbance
  • Gastrointestinal Haemorrhage
  • Haematemesis
  • Pneumonia
  • Respiratory Arrest
  • Shock Haemorrhagic
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Alprostadil efficacy: NA.

Aneurysm, Post Procedural Haematoma
In this report, Alprostadil was administered for the following condition: peripheral ischaemia.A 86-year-old female consumer from GERMANY (weight: NA) started Alprostadil treatment (dosage: 80 Mcg (40 Mcg 2 In 1 Day (s)) Intravenous (not Otherwise Specified)) on Jul 09, 2007.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Aneurysm
  • Post Procedural Haematoma
A possible interaction with other drugs could have contributed to this reaction:
  • Ringers Injection In Plastic Container (400 Ml (200 Ml 2 In 1 Day (s)) Intravenous (not Otherwise Specified))
  • Acetylsalicylic Acid Srt (100 Mg (100 Mg 1 In 1 Day (s)) Oral)
  • Acetylsalicylic Acid Srt (100 Mg (100 Mg 1 In 1 Day (s)) Oral)
  • Clopidogrel Bisulfate (75 Mcmol (75 Mg 1 In 1 Day (s)) Oral)
  • Clopidogrel Bisulfate (75 Mcmol (75 Mg 1 In 1 Day (s)) Oral)
  • Enoxaparin Sodium (80 Mg (40 Mg 2 In 1 Day (s)))
  • Heparin
  • Insulin (insulin)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Alprostadil treatment could be related to the listed above side effect(s).

Respiratory Arrest, Ulcer Haemorrhage
This is a report of the following Alprostadil side effect(s):
  • Respiratory Arrest
  • Ulcer Haemorrhage
A 63-year-old male patient from JAPAN (weight: NA) presented with the following condition: ischaemic ulcer and received a treatment with Alprostadil (dosage: 80 Mcg Intravenous Drip) starting: Aug 01, 2007.The following concurrently used drugs could have generated interactions:
  • Aspirin
  • Aluminium Glycinate
  • Magnesium Carbonate (acetylsalicylic Acid, Aluminium Glycinate, Magnes
The patient was hospitalized.This report suggests that a Alprostadil treatment could be associated with the listed above side effect(s).

Cardiac Failure Acute
This Alprostadil report was submitted by a 75-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: arteriosclerosis obliterans and Alprostadil was administered (dosage: 120 Mcg (60 Mcg 2 In 1 Day (s)) Intravenous Drip) starting: Mar 19, 2007. The consumer developed a set of symptoms:
  • Cardiac Failure Acute
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Alprostadil treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Aneurysm, Haematoma, Post Procedural Complication
This is a report of a possible correlation between Alprostadil use and the following symptoms/side effect(s):
  • Aneurysm
  • Haematoma
  • Post Procedural Complication
which could contribute to an assessment of Alprostadil risk profile.A 86-year-old female consumer from GERMANY (weight: NA) was suffering from peripheral ischaemia and was treated with Alprostadil (dosage: 80 Mcg (40 Mcg 2 In 1 Day (s)) Intravenous (not Otherwise Specified)) starting Jul 09, 2007.Other concurrent medications:
  • Ringers Injection In Plastic Container (400 Ml (200 Ml 2 In 1 Day (s)) Intravenous (not Otherwise Specified))
  • Acetylsalicylic Acid Srt (100 Mg (100 Mg 1 In 1 Day (s)) Oral)
  • Acetylsalicylic Acid Srt (100 Mg (100 Mg 1 In 1 Day (s)) Oral)
  • Clopidogrel Bisulfate (75 Mcmol (75 Mg 1 In 1 Day (s)) Oral)
  • Enoxaparin Sodium (80 Mg (40 Mg, 2 In 1 Day (s)))
  • Heparin
  • Insulin (insulin)
  • Neurotrat (cyanocobalamin, Liver Extract, Pyridoxine Hydrochloride, Th
The patient was hospitalized.

Activities Of Daily Living Impaired, Apathy, Back Pain, Epidermolysis, Muscular Weakness, Neck Pain, Pain In Extremity, Pruritus
A 83-year-old female patient from JAPAN (weight: NA) presented with the following symptoms: arteriosclerosis obliterans and after a treatment with Alprostadil (dosage: 80 Mcg (40 Mcg 2 In 1 Day(s))) experienced the following side effect(s):
  • Activities Of Daily Living Impaired
  • Apathy
  • Back Pain
  • Epidermolysis
  • Muscular Weakness
  • Neck Pain
  • Pain In Extremity
  • Pruritus
The treatment was started on Apr 17, 2007. Alprostadil was used in combination with the following drugs:
  • Clonazepam
  • Nolport (extract From Inflammatory Rabbit Skin Inoculated By Vaccina V (7.2)
  • Kashiwadol (chondroitin Sulfate Sodium, Salicylate Sodium) (40 Mgl)
  • Etizolam (etizolam) (.5 Mg)
  • Furosemide
  • Spironolactone
  • Tocopheryl Nicotinate (tocopheryl Nicotinate)
  • Sennoside
The patient was hospitalized.This report could alert potential Alprostadil consumers.

Activities Of Daily Living Impaired, Anaemia, Arteriosclerosis Obliterans, Blood Disorder, Blood Triglycerides Increased, Dehydration, Depressed Level Of Consciousness, Diabetic Complication, Gangrene
In this report, a 72-year-old male patient from JAPAN (weight: NA) was affected by a possible Alprostadil side effect.The patient was diagnosed with arteriosclerosis obliterans,upper gastrointestinal haemorrhage. After a treatment with Alprostadil (dosage: 60 Mcg (60 Mcg 1 In 1 Day(s)) Intravenous Drip, start date: Apr 27, 2007), the patient experienced the following side effect(s):
  • Activities Of Daily Living Impaired
  • Anaemia
  • Arteriosclerosis Obliterans
  • Blood Disorder
  • Blood Triglycerides Increased
  • Dehydration
  • Depressed Level Of Consciousness
  • Diabetic Complication
  • Gangrene
The following simultaneously used drugs could have led to this reaction:
  • Omeprazole (40 Mg Intravenous Drip)
  • Etizolam (etizolam)
  • Zolpidem Tartrate
  • Furosemide
  • Potassium Canrenoate (potassium Canrenoate)
  • Actit (magnesium Chloride Anhydrous, Maltose, Potassium Chloride, Pota
  • Tienam (cilastatin, Imipenem)
The findings here stress that side effects should be taken into consideration when evaluating a Alprostadil treatment.

Arrhythmia, Atrial Fibrillation, Discomfort, Dizziness Postural, Palpitations
This is a report of a 58-year-old male patient from JAPAN (weight: NA), who used Alprostadil (dosage: 60 Mcg (20 Mcg 3 In 1 Day(s)) Intravenous Drip) for a treatment of arteriosclerosis obliterans. After starting a treatment on Feb 07, 2007, the patient experienced the following side effect(s):
  • Arrhythmia
  • Atrial Fibrillation
  • Discomfort
  • Dizziness Postural
  • Palpitations
The following drugs could possibly have interacted with the Alprostadil treatment
  • Thiamine Disulfide (thiamine Disulfide)
Taken together, these observations suggest that a Alprostadil treatment could be related to side effect(s), such as Arrhythmia, Atrial Fibrillation, Discomfort, Dizziness Postural, Palpitations.

Hypoglycaemia
This hypoglycaemia side effect was reported by a consumer or non-health professional from JAPAN. A 72-year-old male patient (weight:NA) experienced the following symptoms/conditions: arteriosclerosis obliterans. The patient was prescribed Alprostadil (dosage: 60 Mcg (60 Mcg 1 In 1 Day(s)) Intravenous Drip), which was started on Apr 27, 2007. Concurrently used drugs:
  • Etizolam (etizolam)
  • Zolpidem Tartrate
  • Furosemide
  • Potassium Canrenoate (potassium Canrenoate)
  • Omeprazole
When starting to take Alprostadil the consumer reported the following symptoms:
  • Hypoglycaemia
These side effects may potentially be related to Alprostadil.

Cardio-respiratory Arrest, Loss Of Consciousness
This is a Alprostadil side effect report of a 87-year-old female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: lumbar spinal stenosis,hypertension, who was treated with Alprostadil (dosage:60 Mcg (60 Mcg 1 In 1 Day (s)) Intravenous Drip, start time: Oct 20, 2006), combined with:
  • Candesartan Cilexetil (canderastan Cilexetil) (Oral)
  • Benidipine Hydrochloride (benidipine Hydrochloride) (Oral)
  • Neo Vitacain (calcium Bromide, Calcium Pantothenate, Cinchocaine Hydro (1 Df Topical)
  • Hyaluronate Sodium (hyaluronate Sodium) (1 Df Intra-articular)
, and developed a serious reaction and a cardio-respiratory arrest side effect. The patient presented with:
  • Cardio-respiratory Arrest
  • Loss Of Consciousness
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Alprostadil treatment in female patients suffering from lumbar spinal stenosis,hypertension, resulting in cardio-respiratory arrest.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Liver Disorder
This report suggests a potential Alprostadil alanine aminotransferase increased side effect(s) that can have serious consequences. A 55-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): arterial occlusive disease and used Alprostadil (dosage: 120 Mcg (120 Mcg 1 In 1 Day(s)) Intravenous Drip) starting Dec 29, 2006. Soon after starting Alprostadil the patient began experiencing various side effects, including:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Blood Alkaline Phosphatase Increased
  • Blood Lactate Dehydrogenase Increased
  • Liver Disorder
Drugs used concurrently:
  • Sarpogrelate Hydrochloride (sarpogrelate Hydrochloride)
  • Amino Acids (amino Acids Nos)
  • Cefotiam Hydrochloride
Although Alprostadil demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as alanine aminotransferase increased, may still occur.

Pleural Effusion
This pleural effusion problem was reported by a consumer or non-health professional from JAPAN. A 65-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): arteriosclerosis obliterans.On Feb 14, 2007 a consumer started treatment with Alprostadil (dosage: 60 Mcg Intravenous Drip). The following drugs/medications were being taken at the same time:
  • Pletal
When commencing Alprostadil, the patient experienced the following unwanted symptoms /side effects:
  • Pleural Effusion
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as pleural effusion, may become evident only after a product is in use by the general population.

Priapism
This is a Alprostadil side effect report of a 60-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: erectile dysfunction and was treated with Alprostadil (dosage: 20 Mcg As Needed Intracavern) starting Mar 07, 2007. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Priapism
The patient was hospitalized. This opens a possibility that Alprostadil could cause priapism and that some male patients may be more susceptible.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal, Liver Disorder
A 55-year-old male patient (weight: NA) from JAPAN with the following symptoms: arteriosclerosis obliterans started Alprostadil treatment (dosage: 120 Mcg (120 Mcg 1 In 1 Day (s))) on Dec 29, 2006. Soon after starting Alprostadil treatment, the consumer experienced several side effects, including:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Hepatic Function Abnormal
  • Liver Disorder
. Concurrently used drugs:
  • Sarpogrelate Hydrochloride
  • Kidmin (amino Acids Nos)
  • Cefotiam Hydrochloride
This finding indicates that some patients can be more vulnerable to developing Alprostadil side effects, such as alanine aminotransferase increased.

Asthenia, Blood Pressure Decreased, Continuous Haemodiafiltration, Inflammation, Malaise, Pyrexia, Renal Failure Acute
This asthenia side effect was reported by a consumer or non-health professional from JAPAN. A 77-year-old female patient (weight:NA) experienced the following symptoms/conditions: lumbar spinal stenosis.The patient was prescribed Alprostadil (dosage: 80 Mcg (80mcg 1 In 1 Day(s))), which was started on Aug 24, 2006. Concurrently used drugs:
  • Sodium Bicarbonate In Plastic Container
  • Etodolac (400 Mg)
  • Valsartan
  • Doxazosin Mesylate
  • Amlodipine Besylate
  • Terbinafine Hcl
  • Alendronate Sodium
  • Senna Leaf (senna Leaf)
.When starting to take Alprostadil the consumer reported symptoms, such as:
  • Asthenia
  • Blood Pressure Decreased
  • Continuous Haemodiafiltration
  • Inflammation
  • Malaise
  • Pyrexia
  • Renal Failure Acute
These side effects may potentially be related to Alprostadil. The patient was hospitalized.

Anaemia, Anuria, Cardiac Failure Congestive, Condition Aggravated, Hepatic Failure, Hepatorenal Syndrome, Platelet Count Decreased, Renal Failure Acute
This is a report of a 86-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: arteriosclerosis obliterans, who was treated with Alprostadil (dosage: 40 Mcg (20 Mcg 2 In 1 Day(s)); Intravenous Drip, start time: Nov 13, 2006), combined with:
  • Carvedilol
  • Azosemide
  • Paroxetine Hydrochloride
  • Allopurinol Sodium
  • Niceritrol
  • Chinese Medicine
and developed a serious reaction and side effect(s). The consumer presented with:
  • Anaemia
  • Anuria
  • Cardiac Failure Congestive
  • Condition Aggravated
  • Hepatic Failure
  • Hepatorenal Syndrome
  • Platelet Count Decreased
  • Renal Failure Acute
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Alprostadil treatment in male patients, resulting in anaemia side effect.

Haematoma, Penile Pain
This report suggests a potential Alprostadil Haematoma, Penile Pain side effect(s) that can have serious consequences. A 54-year-old male patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Alprostadil (dosage: NA) starting NS. Soon after starting Alprostadil the patient began experiencing various side effects, including:
  • Haematoma
  • Penile Pain
Drugs used concurrently: NA.The patient was hospitalized. Although Alprostadil demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as haematoma, may still occur.

Arterial Occlusive Disease, Gastrointestinal Haemorrhage
This Arterial Occlusive Disease, Gastrointestinal Haemorrhage problem was reported by a consumer or non-health professional from JAPAN. A 80-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: thromboangiitis obliterans,arterial occlusive disease. On Mar 01, 2001 this consumer started treatment with Alprostadil (dosage: 80 Mcg (40 Mcg 2 In 1 Day (s)) Intravenous Drip). The following drugs were being taken at the same time:
  • Abbokinase (Intravenous)
  • Warfarin Sodium (Oral)
  • Mecobalamin (mecobalamin)
  • Amitriptyline Hydrochloride
  • Loxoprofen Sodium (loxoprofen Sodium)
  • Famotidine
  • Valsartan
  • Aspirin
When commencing Alprostadil, the patient experienced the following unwanted symptoms/side effects:
  • Arterial Occlusive Disease
  • Gastrointestinal Haemorrhage
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as arterial occlusive disease, may become evident only after a product is in use by the general population.

Acute Myocardial Infarction
This is a report of a 77-year-old male patient (weight: NA) from RUSSIAN FEDERATION. The patient developed the following symptoms/conditions: peripheral ischaemia and was treated with Alprostadil (dosage: 2 X 40 Ug Per Day) starting Dec 04, 2006. Concurrently used drugs:
  • Phenazepam 0.5 Mg, Tablets (phenazepam)
  • Ndapamide 1.5mg Tablets Sr
  • Enalapril Maleate
  • Acetylsalicylic Acid 125mg Tablets
  • Verapamil 40 Mg Tablets
  • Calf Blood Dialysate 10 Mg, Solution (blood, Calf, Deprot., Lmw Portio
  • Thioctic Acid 300mg, Solution (thioctic Acid)
  • Furosemide 40 Mg, Solution (furosemide)
Soon after that, the consumer experienced the following side effects:
  • Acute Myocardial Infarction
This opens a possibility that Alprostadil treatment could cause the above reactions, including acute myocardial infarction, and some male subjects may be more susceptible.


A 77-year-old male patient (weight: NA) from RUSSIAN FEDERATION with the following symptoms/conditions: peripheral ischaemia started Alprostadil treatment (dosage: 2 X 40 Ug Per Day) on Dec 04, 2006. Soon after starting Alprostadil treatment, the subject experienced various side effects, including:
    Concurrently used drugs:
    • Phenazepam
    • Indapamide
    • Enalapril Maleate
    • Acetylsalicylic Acid Tablets (acetylsalicylic Acid)
    • Verapamil
    • Calf Blood Dialysate Solution (blood, Calif, Deprot., Lmw Portion)
    • Thioctic Acid 300mg, Solution (thioctic Acid)
    • Furosemide Solution (furosemide)
    This finding indicates that some male patients could be more vulnerable to Alprostadil.

      6 of 11 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Alprostadil Side Effects

    Did You Have a Alprostadil Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Alprostadil for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Alprostadil Safety Alerts, Active Ingredients, Usage Information

    NDC0703-1501
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameAlprostadil
    NameAlprostadil
    Dosage FormINJECTION
    RouteINTRAVASCULAR
    On market since19990430
    LabelerTeva Parenteral Medicines, Inc
    Active Ingredient(s)ALPROSTADIL
    Strength(s)500
    Unit(s)ug/mL
    Pharma ClassGenitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],P

    More About Alprostadil

    Side Effects reported to FDA: 253

    Alprostadil safety alerts: No

    Reported deaths: 48

    Reported hospitalizations: 102

    Latest Alprostadil clinical trials